NURE
Nuveen Short-Term REIT ETF
The NuShares Short-Term REIT ETF tracks an index composed of U.S. REITs that typically have shorter-term lease durations than average.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 33.3 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Dec 19, 2016 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| INVITATION HOMES, INC. | 5.3 % |
| RYMAN HOSPITALITY PROPERTIES | 5.3 % |
| AMERICAN HOMES 4 RENT- A | 5.2 % |
| HOST HOTELS & RESORTS INC | 5.2 % |
| EQUITY RESIDENTIAL | 5.1 % |
| AVALONBAY COMMUNITIES INC | 5.0 % |
| ESSEX PROPERTY TRUST INC | 5.0 % |
| CUBESMART | 4.9 % |
| CAMDEN PROPERTY TRUST | 4.8 % |
| UDR INC | 4.8 % |
Constituent Breakdown
| Number of holdings | 31 |
| Herfindahl-Hirschman Index | 417 |
| Wgt avg mkt cap (mns) | $13,435 |
| Large cap (>$10bn) | 64.8% |
| Mid cap ($2-10bn) | 19.4% |
| Small cap (<$2bn) | 13.1% |
| Developed mkts. | 98.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 99.9 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.1% | 0.1% | 0.7% | -0.2% | -1.7% | -- | -- | 1.9% |
| Dividend Yield | 1.5% | 5.0% | 4.3% | 4.2% | 3.4% | -- | -- | 3.7% |
| Total Returns | 7.6% | 5.1% | 5.0% | 3.9% | 1.7% | -- | -- | 5.5% | Ann. Volatility | 17.4% | 16.4% | 17.6% | 17.8% | 19.7% | -- | -- | 34.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.54 | 17% |
| MSCI EAFE | 0.54 | 23% |
| MSCI Emg Mkts | 0.25 | 8% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.14% |
Technical Indicators
| 30d moving avg. (EMA) | $28.84 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 0.45/0.37 |
| Bollinger Bands (Upper/Lower) | $30.27/$27.75 |
| Short interest (% of AUM) | 2.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. NURE |
Expenses vs. NURE |
ALTAR Score™ vs. NURE |
|---|---|---|---|---|
| HAUS | Residential REIT ETF | 60.8% | +25 bp | -4.1% |
| REZ | iShares Residential and Multisector Real Estate ETF | 47.3% | +13 bp | -1.8% |
| RSPR | Invesco S&P 500 Equal Weight Real Estate ETF | 31.5% | +5 bp | -0.2% |
| IRET | iREIT - MarketVector Quality REIT Index ETF | 31.5% | +25 bp | -1.7% |
| RWR | State Street SPDR Dow Jones REIT ETF | 27.9% | -10 bp | -0.9% |
| BBRE | JPMorgan BetaBuilders MSCI U.S. REIT ETF | 26.5% | -24 bp | -0.5% |
| ICF | iShares Cohen & Steers REIT ETF | 25.8% | -2 bp | -0.6% |
| USRT | iShares Core U.S. REIT ETF | 25.3% | -27 bp | -0.7% |
| JPRE | JPMorgan Realty Income ETF | 24.9% | +15 bp | -0.7% |
| PPTY | US Diversified Real Estate ETF | 24.2% | +18 bp | +0.1% |
Risk and Returns: NURE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/7/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
8.1%
ALTAR SCORE™
90th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,206 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. NURE's ALTAR Score™ is approximately 1.3 standard
deviations above the category average. This places NURE in the 90th percentile
among funds in the category.
Sell-Side Consensus
$32.72
PRICE TARGET
+7.8%
UPSIDE